Abstract
Bacteria they are the largest source of clinically used antibiotics. Genome sequencing of bacterial strains has identified hundreds of pathways responsible for antibiotic production. As antibiotic resistance is now a global problem (http://www.who.int/antimicrobial-resistance/en/) many scientists are interested in using synthetic biology to engineer bacteria to produce new antibiotics. We are currently studying a biochemical pathway in a bacterial strain responsible for producing an antibiotic with activity against tuberculosis. The goal of this project is to elucidate this pathway using mutagenesis, characterize key biosynthetic enzymes and engineer the pathway to produce novel derivatives.
References
- Kim, E., Moore B. S & Yoon Y. J. (2015) Reinvigorating natural product combinatorial biosynthesis with synthetic biology Nat. Chem. Biol. 11, 649–659
- Barry, S. M., Kers, J. A., Johnson, E. R., Song, L., Aston, P. R., Patel, B., Krasnoff, S. B., Gibson, D. M., Loria, R., Challis, G. L. (2012) Cytochrome P450-catalysed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis. Nat. Chem. Biol. 8, 814-816.
- Hubert, C. B. and Barry, S. M. New Chemistry from Natural Product Biosynthesis Biochem. Soc. Trans. 2016, 44, 738-744
- M.M. Roessler, R.M. Evans, R.A. Davies, J. Harmer, and F.A. Armstrong (2012) ‘EPR Spectroscopic Studies of the Fe–S Clusters in the O2-Tolerant [NiFe]-Hydrogenase Hyd-1 from Escherichia coli and Characterization of the Unique [4Fe–3S] Cluster by HYSCORE’ J. Am. Chem. Soc. 134 (37), 15581–15594.
- J. J. Wright, E. Salvadori, H. R. Bridges, J. Hirst & M. M. Roessler (2016), ‘Small-volume potentiometric titrations: EPR investigations of Fe-S cluster N2 in mitochondrial complex I’ J. Inorg. Biochem., 162, 201-206.